Ludwigia adscendens subsp. diffusa, an aquatic plant with an extended tradition of use in conventional healthcare, has received growing recognition for its variety of bioactive compounds. Numerous components, notably flavonoids, phenolics, tannins, alkaloids, and terpenoids, have been shown through phytochemical analyses to be responsible for the plant's pharmacological effects. These compounds are known to have actions such as antioxidant, anti-inflammatory, antimicrobial, antidiabetic properties, and anticancer effects. Initial phytochemical and pharmacological screenings have indicated therapeutic potential in addressing cardiovascular diseases, diabetes, and microbial infections; however, the current data are still incomplete. A comprehensive chemical characterization and an extensive assessment of its pharmacological effects are essential for enhancing our comprehension of its curative properties. Whereas in vitro and in vivo findings are promising, further investigation into clinical relevance and safety profiles is necessary to confirm L. adscendens as a potential therapeutic agent.
Easha et al. (Thu,) studied this question.